Genpact Awarded Two U.S. Patents that Help Companies Increase Value from Process Transformation and Intelligent Automation

Rhea-AI Summary

Genpact (NYSE:G) has secured two patents from the U.S. Patent and Trademark Office for innovative business transformation frameworks: Genpact ProcIndex and Intelligent Automation Index. ProcIndex measures process health using analytics, helping companies identify improvement opportunities, while the Intelligent Automation Index assesses automation potential across processes. By leveraging these tools, Genpact enables firms to drive operational efficiency and optimize ROI. Both frameworks have been successfully implemented by over 100 clients, leading to significant improvements in process efficiency and cost reduction.

Positive

• Secured two patents for innovative business transformation frameworks.
• ProcIndex reduced identification time for transformation opportunities by 50% for a leading CPG company.
• Intelligent Automation Index decreased process cycle times by up to 75% for a global diversified bank.

Negative

• None.

NEW YORK, March 15, 2021 /PRNewswire/ -- Genpact (NYSE:G), a professional services firm focused on delivering digital transformation, announced today that the United States Patent and Trademark Office has awarded the company two patents for business transformation frameworks: the first for Genpact ProcIndex, a diagnostic tool that uses smart analytics and automation to measure process health, and a second for its Intelligent Automation Index, designed to drive greater value from digital investments by identifying where automation will have its biggest potential. Both Genpact patents allow companies to generate insights at speed to deliver strategic business outcomes.

Widespread digital disruption has put transformation at the heart of many business strategies, underscoring the importance of innovative tools companies can use to reimagine operations, while helping to optimize return on investment. Genpact ProcIndex and the Intelligent Automation Index both address these needs, and leverage Genpact's digital technology, domain expertise, and deep experience in process improvement to provide meaningful business transformation.

Genpact ProcIndex tracks and evaluates both quantitative and qualitative process health parameters across the enterprise via cutting-edge methodologies and diagnostic tools to interpret data intelligently. Built on cloud technology and leveraging Genpact's Smart Enterprise Processes (SEP^SM) proprietary framework, ProcIndex creates a holistic view that can measure and quantify the state of finance and accounting process health against best-in-class models to drive strategic process innovation, standardization, and plan for enterprise transformation. This approach provides a major improvement over traditional benchmarking methods that do little to identify a process' overall health.

The Intelligent Automation Index creates a detailed roadmap to deploy technology that can drive increased value across an enterprise. Powered by more than half a million unique algorithm combinations that assess the automation potential of processes, it designs, and evaluates end-to-end automation processes. The index combines process-centric digital technologies, Lean methods, and analytics with design-thinking methodologies to pinpoint areas to maximize return on investments, enabling businesses to make the best technology investment decisions. It objectively assesses an organization's existing level of automation maturity and identifies activities within processes that companies can automate using digital interventions, such as robotic process automation, machine learning, and cognitive intelligence. 

"Leading organizations need to derive insights at speed, and these patents exemplify a holistic, integrated approach that help transform operations, drive strategic process innovation, and deploy the right technologies to enable long-term gains for enterprise transformation," said Katie Stein, chief strategy officer and global business leader, Enterprise Services, Genpact. "Genpact's patents demonstrate our commitment to innovation and our ability to help clients' transformation journeys."

As an integral part of Genpact's transformation approach, both patented frameworks have been used by more than 100 clients. For example, ProcIndex helped a leading global consumer packaged goods company improve the effectiveness of its enterprise processes, cutting the time it took to identify significant transformation opportunities by 50%, leading to a 40% reduction in its cost of finance operations. And, using the Intelligent Automation Index with a global diversified bank, Genpact reduced process cycle times by up to 75%, driving greater accuracy and heightened productivity.

About Genpact
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. Led by our purpose -- the relentless pursuit of a world that works better for people -- we drive digital-led innovation and digitally enabled intelligent operations for our clients. Guided by our experience reinventing and running thousands of processes for hundreds of clients, many of them Global Fortune 500 companies, we drive real-world transformation at scale. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 90,000+ of us. From New York to New Delhi, and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent the ways companies work. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we'll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here. Get to know us at Genpact.com and on LinkedIn, Twitter, YouTube, and Facebook.

MEDIA CONTACTS:

Danielle D'Angelo
Genpact Media Relations – Americas
+1 914-336-7951
danielle.dangelo@genpact.com

Siya Belliappa
Genpact Media Relations – India
+91 9823133365
siya.belliappa@genpact.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/genpact-awarded-two-us-patents-that-help-companies-increase-value-from-process-transformation-and-intelligent-automation-301247074.html

SOURCE Genpact

FAQ

What patents did Genpact receive on March 15, 2021?

Genpact received two patents for Genpact ProcIndex and Intelligent Automation Index.

How does Genpact ProcIndex benefit companies?

It measures process health using smart analytics and helps identify transformation opportunities.

What is the main function of the Intelligent Automation Index?

It assesses automation potential across processes to drive value from digital investments.

How many clients have used Genpact's patented frameworks?

Over 100 clients have successfully implemented the patented frameworks.

What improvements did clients achieve using Genpact's frameworks?

Clients reported up to 75% reduction in process cycle times and 40% reduction in finance operation costs.